Profile change history

What changed for Dasiglucagon?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Dasiglucagon identity.

20Total events
20Record additions
0Version changes
8Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 20 connected records →

Showing the latest 20 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 16, 2026.

Record added

ClinicalTrials.gov record NCT02916251

PeptideScanner retained ClinicalTrials.gov record NCT02916251 at 2026-11-16T01:42:39.027Z. Its registry update date was 2017-04-21, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
April 21, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03216226

PeptideScanner retained ClinicalTrials.gov record NCT03216226 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-05-04, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
May 4, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03378635

PeptideScanner retained ClinicalTrials.gov record NCT03378635 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-06-10, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
June 10, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03667053

PeptideScanner retained ClinicalTrials.gov record NCT03667053 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-06-30, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
June 30, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03688711

PeptideScanner retained ClinicalTrials.gov record NCT03688711 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-05-19, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
May 19, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03735225

PeptideScanner retained ClinicalTrials.gov record NCT03735225 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-03-23, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
March 23, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03777176

PeptideScanner retained ClinicalTrials.gov record NCT03777176 at 2026-11-16T01:42:39.027Z. Its registry update date was 2023-12-13, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
December 13, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03840278

PeptideScanner retained ClinicalTrials.gov record NCT03840278 at 2026-11-16T01:42:39.027Z. Its registry update date was 2019-12-16, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
December 16, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03895697

PeptideScanner retained ClinicalTrials.gov record NCT03895697 at 2026-11-16T01:42:39.027Z. Its registry update date was 2023-02-21, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
February 21, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03941236

PeptideScanner retained ClinicalTrials.gov record NCT03941236 at 2026-11-16T01:42:39.027Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
August 3, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03984370

PeptideScanner retained ClinicalTrials.gov record NCT03984370 at 2026-11-16T01:42:39.027Z. Its registry update date was 2020-03-31, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
March 31, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04172441

PeptideScanner retained ClinicalTrials.gov record NCT04172441 at 2026-11-16T01:42:39.027Z. Its registry update date was 2025-03-14, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
March 14, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04449692

PeptideScanner retained ClinicalTrials.gov record NCT04449692 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-02-09, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
February 9, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04764968

PeptideScanner retained ClinicalTrials.gov record NCT04764968 at 2026-11-16T01:42:39.027Z. Its registry update date was 2022-09-07, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
September 7, 2022
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04836273

PeptideScanner retained ClinicalTrials.gov record NCT04836273 at 2026-11-16T01:42:39.027Z. Its registry update date was 2023-02-02, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
February 2, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05378672

PeptideScanner retained ClinicalTrials.gov record NCT05378672 at 2026-11-16T01:42:39.027Z. Its registry update date was 2025-07-20, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
July 20, 2025
Evidence lane
Clinical trials
Record added

Federal Register notice 2023-26260

The Federal Register published notice 2023-26260, attributed to FDA and its parent HHS department, on 2023-11-30. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; ZEGALOGUE,” and PeptideScanner's exact reviewed identity mapping connects the document to Dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
November 30, 2023
Evidence lane
Regulatory
Record added

Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting.

PubMed lists PMID 33906916 in Diabetes care as Letter, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-04-27 (day precision). PeptideScanner associated the retained record with the identity slug dasiglucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata
Record added

Dasiglucagon Hydrochloride.

PubMed lists PMID 33998648 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2021-07-22 (day precision). PeptideScanner associated the retained record with the identity slug dasiglucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata